Stockreport

Inventiva provides a corporate update and reports its unaudited 2024 first-half financial results

Inventiva S.A. - American Depository Shares  (IVA) 
PDF Recruitment in NATiV3 clinical trial progresses with over 85% of the targeted number of patients enrolled in the main cohort and a statistical powering of the study expe [Read more]